5 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 8 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 8 | Completed 5, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study Atomoxetine, Placebo - ADHD, Primary Nocturnal Enuresis | Early Phase 1 | Not yet recruiting | Tanta University | 100 | 2025-02-28 | 2025-02-27 |
| Relapse Prevention in Stimulant Use Disorder Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion - Stimulant Use, Relapse | Early Phase 1 | Withdrawn | University of California, Los Angeles | 2023-06-11 | 2023-09-22 | |
| Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD Lidocaine gel - ADHD, PMS | Early Phase 1 | Completed | PhenoSolve, LLC | 90 | 2019-08-14 | 2022-10-06 |
| Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness Lidocaine gel, Placebo, Injected lidocaine - ADHD, Controls | Early Phase 1 | Completed | PhenoSolve, LLC | 20 | 2019-08-01 | 2020-07-15 |
| Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD Lidocaine gel - ADHD | Early Phase 1 | Completed | PhenoSolve, LLC | 28 | 2018-01-20 | 2021-07-02 |
| Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet BP22042013, Low carbohydrate diet - ADD, ADHD | Early Phase 1 | Completed | Spanish Foundation for Neurometrics Development | 100 | 2015-06-01 | 2021-04-08 |
| Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein BP22042013, Low carbohydrate diet - ADD, ADHD | Early Phase 1 | Completed | Spanish Foundation for Neurometrics Development | 64 | 2013-12-01 | 2024-05-08 |
| Amiloride Hydrochloride as an Effective Treatment for ADHD amiloride, Behavioral - ADHD | Early Phase 1 | Terminated | State University of New York - Upstate Medical University | 3 | 2012-09-01 | 2018-07-20 |
Attention Deficit Disorder with Hyperactivity (8) · Emotional Regulation (1) · Recurrence (1)
Attention Deficit and Disruptive Behavior Disorders (8) · Mental Disorders (8) · Neurodevelopmental Disorders (8) · Behavior (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Self-Control (1) · Social Behavior (1)
Methods (3) · Diet, Carbohydrate-Restricted (2) · Amiloride (1) · Atomoxetine Hydrochloride (1) · Bupropion (1) · bupropion hydrochloride, naltrexone hydrochoride drug combination (1)
PhenoSolve, LLC (3) · Spanish Foundation for Neurometrics Development (2) · State University of New York - Upstate Medical University (1) · Tanta University (1) · University of California, Los Angeles (1)
United States (5) · United Kingdom (1)
Michael Segal, MD PhD (3) · Edythe D London, Ph.D. (1) · Moises Aguilar-Domingo, PhD (1) · Prashant Kaul, MD (1) · Stephen V Faraone, PhD (1)
PMID 11143733, PMID 18174562, PMID 18426576, PMID 23134619, PMID 24761279, PMID 24938135, PMID 25447751, PMID 9212254